SARS-CoV2 infection in children in Switzerland

Key facts

Disease
COVID-19
Start & end year
2021
Known Financial Commitments (USD)
$274,964.56
Funder
Federal Office of Public Health (FOPH)
Principal Investigator
Abteilung Übertragbare Krankheiten Sekretariat der
Research Location
Switzerland
Lead Research Institution
N/A
Research Priority Alignment
N/A

Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adolescent (13 years to 17 years)Children (1 year to 12 years)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Knowledge about the course of illness in children and adolescents infected with SARS-CoV-2 is limited. This project aims to help close this knowledge gap. Various parameters are being collected from children and adolescents treated for COVID-19 in Swiss hospitals to gain insights into, among other things, the incidence, clinical presentation and severity of the disease, PIMS-TS (Multisystem Syndrome Temporally related to SARS-CoV-2), disease progression, and treatment options.